As the agricultural biotechnology market expands, a critical challenge remains: ensuring equitable access to biotech innovations across diverse global contexts. While high-income countries benefit from advanced gene-editing tools and digital agriculture platforms, smallholder farmers in low- and middle-income countries often face barriers related to cost, regulation, and infrastructure. Bridging this gap is essential for achieving global food security and sustainability goals.

The market was valued at USD 247.77 billion in 2024 and is projected to reach USD 632.93 billion by 2035, growing at a CAGR of approximately 8.9%. Growth is driven by rising food demand, increasing focus on sustainable farming, advancements in gene-editing technologies (like CRISPR), development of climate-resilient crops, and growing use of bio-based inputs to reduce environmental impact.

By crop type, soybean dominates due to its widespread use in oil production and animal feed. Maize is the fastest-growing segment, driven by applications in food, biofuels, and industrial uses. Cotton and other crops also contribute significantly.

Application-wise, herbicide tolerance holds the largest share, enabling efficient weed management. Stacked traits (combining multiple beneficial traits) are the fastest-growing, offering comprehensive solutions for pest resistance, drought tolerance, and yield enhancement.

Technique segmentation shows genetic engineering as the largest, while molecular breeding is the fastest-growing, offering precise trait improvement without extensive genetic modification. Molecular diagnostics and tissue culture also play vital roles in disease detection and plant propagation.

Regionally, North America leads with over 45% share, supported by advanced research, strong investment, and supportive regulations. Europe follows with 30%, driven by sustainability goals. Asia-Pacific holds 20% and is growing rapidly, fueled by population growth and government initiatives. Middle East and Africa, though smaller (5%), are emerging due to food security needs.

Key players include Bayer, Monsanto (now part of Bayer), Syngenta, DuPont, BASF, Dow AgroSciences, Corteva Agriscience, Limagrain, and KWS SAAT. Strategies focus on gene editing, digital agriculture platforms, biopesticides, and strategic partnerships to accelerate innovation.

Read more: Agricultural Biotechnology Market

People Also Ask

Q1. What are the main barriers to biotech access in low-income countries?
Key barriers include high costs of seeds and technologies, restrictive regulatory frameworks, limited infrastructure for distribution and training, and lack of awareness or acceptance among smallholder farmers.

Q2. How is the industry addressing global equity in ag biotech?
The industry is addressing equity through public-private partnerships, tiered pricing models, capacity-building programs for farmers, and advocacy for streamlined regulations that enable access to climate-resilient and high-yield crops.

Tags: agricultural biotechnology, global food security, equitable access, smallholder farmers, sustainable agriculture, regulatory frameworks